Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

53.97
Delayed Data
As of May 26
 -0.42 / -0.77%
Today’s Change
46.01
Today|||52-Week Range
77.12
-7.65%
Year-to-Date
Celldex's Immuno-Oncology Pipeline Continues to Impress
May 26 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Q1 Earnings Fall Y/Y, Revenues Increase
May 19 / Zacks.com - Paid Partner Content
Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer
May 26 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More
May 19 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data
May 26 / Zacks.com - Paid Partner Content
Incyte (INCY) Announces Positive Data on Enzyme Inhibitor
May 18 / Zacks.com - Paid Partner Content
Dodge & Cox Buys Express Scripts, Bristol-Myers, HP
May 25 / GuruFocus News - Paid Partner Content
Biogen (BIIB) Buys Stroke Candidate Cirara for $120M
May 16 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets Priority Review for Liver Cancer
May 25 / Zacks.com - Paid Partner Content
US retail real estate extends its bruising slide
May 16 / FT.com - Paid Partner Content
Boston Common Asset Management, LLC Buys Sociedad Quimica Y Minera De Chile SA, Albem...
May 25 / GuruFocus News - Paid Partner Content
AstraZeneca Imfinzi Positive in Phase III Lung Cancer Study
May 15 / Zacks.com - Paid Partner Content
Old Republic International Corp Buys VF Corp, Entergy Corp, Bristol-Myers Squibb Comp...
May 22 / GuruFocus News - Paid Partner Content
French back at polls, US pharma results, Fed sets interest rates
Apr 30 / FT.com - Paid Partner Content
New Research Reports for Britol-Myers, Pricline & Phillips 66
May 19 / Zacks.com - Paid Partner Content